Skip to main content
. 2020 Dec 28;15(12):e0244348. doi: 10.1371/journal.pone.0244348

Table 1. Demographic characteristics and antibody reactivity of participants.

Characteristics Participants n (%) Positive SARS-CoV-2 IgG S1/S2 n (%) Positive SARS-CoV-2 IgG S1/S2 or SARS-CoV-2 IgG N n (%)* No. negative IgG S1/S2 (%) No. negative IgG N (%)
Entire sample 7563 (100) 712 (9.41) 779 (10.30) 6801 (83.92) 519/591**(87.82)
Sex
Male 1789 (23.65) 181 (10.11) 192 (10.73) 1597 (89.27) 106 (5.92)
Female 5673 (75) 522 (9.20) 575 (10.13) 5144 (90.68) 407 (7.17)
NA 101 (1.33) 9 (9.73) 12 (11.88) 90 (89.11) 6 (5.94)
Age
18–34 2025 (26.78) 209 (23.36) 228 (11.25) 1806 (89.19) 169 (8.34)
35–54 3664 (48.45) 330 (9) 354 (9.61) 3321 (90.64) 241(6.58)
≥55 1771 (23.42) 179 (25.14) 186 (10.50) 1582 (89.33) 103 (5.81)
NA 103(1.36) 9 (1.26) 12 (11.43) 92 (89.32) 6 (5.82)
Location
Primary Care 4153 (54.91) 381 (9.17) 415 (9.99) 3740 (90.06) 283 (6.81)
Tertiary Care 3410 (45.09) 331 (9.71) 364 (10.67) 3061 (89.77) 236 (6.92)
Health Care Job
Nurse 2243 (29.64) 216 (9.62) 239 (10,64) 2016 (89.88) 173 (7.71)
Physician 1821 (24.08) 192 (26.96) 215 (11.70) 1612 (87.70) 126 (6.92)
Nursing Assistant 832 (11) 85 (11.93) 116 (10.52) 745 (89.54) 55 (6.61)
Health Care Support Services 429 (5.67) 33 (4.63) 33 (7.69) 394 (91.84) 27 (6.29)
Administrative Healthcare 1181 (15.62) 75 (10.53) 77 (6.52) 1097 (92.89) 71 (6.01)
Other 616 (8.14) 51 (7.16) 52 (8.44) 562 (91.23) 22 (3.57)
NA 441 (5.83) 60 (8.42) 69 (15.65) 375 (85.03) 45 (10.220)
COVID Symptoms
Yes 3475 (45.95) 523 (15.05) 567 (16.32) 2923 (63.61) 232 (6.68)
No 3646 (48.21) 129 (3.53) 143 (3.92) 3502 (96.05) 243 (6.66)
NA 442 (5.84) 60 (13.57) 69 (5.61) 376 (85.07) 44 (9.95)
Previous COVID Diagnosis
Yes 385 (5.09) 291 (75.58) 313 (81.30) 82 (21.29) 21 (5.45)
No 6740 (89.12) 362 (5.37) 398 (5.90) 6346 (94.15) 456 (6.76)
NA 438 (5.79) 59 (13.47) 68 (15.52) 373 (85.16) 42 (9.59)
SARS-CoV-2 Confirmed rRT-PCR Positive
Yes 341 (4.51) 279 (81.81) 301 (88.26) 50 (14.66) 16 (4.69)
Hospital admitted for COVID
Yes 59 (0.78) 46 (77.97) 46 (77.97) 13 (22.03) 1 (1.69)
No 7044 (93.14) 605 (8.59) 663 (9.41) 6395 (90.79) 474 (6.73)
NA 460 (6.08) 61 (13,26) 70 (15.20) 393 (85.43) 44 (9.56)

*N antigen determination was performed in 646 participants, according to the laboratory analysis algorithm.

** Total samples IgG S1/S2 (>3.80 AU/mL and <15 AU/mL) negative and processed by Abbott IgG N: 591. NA (Not answered).